Cite
HARVARD Citation
Briukhovetska, D. et al. (n.d.). P09.03 Activation of IL-22 signaling correlates with higher CD155 expression and stratifies poor outcomes of early-stage lung and breast cancer patients. Journal for immunotherapy of cancer. p. A33. [Online].